Skip to main content
Caplight Logo









PharmaZen Ltd

PharmaZen Ltd

Private
ChristchurchHealthcare & Life Scienceshttps://pharmazen.co.nz

Last Round

Early Funding

Mar 1, 2026

Est. Valuation

$72.93M

Total Funding Raised

$12.17M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PharmaZen Ltd operates in Healthcare & Life Sciences and is based in Christchurch. Its latest recorded funding round was a Private Equity round in January 2021.

PharmaZen Ltd is a biotechnology company that develops, manufactures, and markets natural nutritional ingredients and dietary supplements for human and animal health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Circular Economy, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PharmaZen Ltd Comparables

Compare PharmaZen Ltd with similar companies based on industry and business-model similarity.

PharmaZen Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmaNZ Limited
80%
Aroma New Zealand Ltd
79%
SeaDragon Marine Oils
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PharmaZen Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 1, 2026
Early FundingDec 1, 2024
Private EquityJan 18, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

PharmaZen Ltd Investors

Notable investors and investment history

PharmaZen Ltd investors
InvestorRounds
Cibus CapitalPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 188% MoM, reaching 2.4K.

  • Mar 1, 2026

    Raised an early funding round.

Book a demo to see all signals

For institutional investors. Book with your work email.

PharmaZen Ltd Filings

Explore SEC and related filing metadata, where available.

PharmaZen Ltd filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PharmaZen Ltd's valuation, stock price, and market status.

Is PharmaZen Ltd a public or private company?

PharmaZen Ltd is a private company.

What is the current stock price of PharmaZen Ltd?

PharmaZen Ltd is a private company, so its shares have no public market price. Caplight tracks PharmaZen Ltd's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PharmaZen Ltd worth (valuation)?

PharmaZen Ltd's valuation is estimated at $72.9M based on funding round data.

Can I buy PharmaZen Ltd stock?

PharmaZen Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PharmaZen Ltd's last funding round?

PharmaZen Ltd's most recent funding round was Early Funding on March 1, 2026.

Who are the main investors in PharmaZen Ltd?

Key investors in PharmaZen Ltd include Cibus Capital.

Will PharmaZen Ltd IPO soon?

No public IPO plans have been announced for PharmaZen Ltd.

How can I track PharmaZen Ltd secondary market activity?

Caplight tracks bids, offers, and trades in PharmaZen Ltd's shares on secondary markets.

Firmographic Details

HeadquartersChristchurch
Employee Range5
Year Founded2001
Last FundingMar 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?